Krogulski Kenneth's Form 4 filing
Cumberland Pharmaceuticals Inc (CPIX) · filed Jan 7, 2022
- Accession no.
- 0001209191-22-002451
- Filed
- Jan 7, 2022
- Trade date
- Dec 1-20, 2021
- Filing delay
- 37 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions. Open-market purchases total $8.82K. It was filed 37 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krogulski KennethCIK 0001695580 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | Common Stock | PPurchaseAcquired | +75 | $4.14 | +$310.5 | 181,260 | Direct | |
| Dec 2, 2021 | Common Stock | PPurchaseAcquired | +75 | $3.84 | +$288 | 181,335 | Direct | |
| Dec 3, 2021 | Common Stock | PPurchaseAcquired | +75 | $4.47 | +$335.25 | 181,410 | Direct | |
| Dec 6, 2021 | Common Stock | PPurchaseAcquired | +75 | $4.46 | +$334.5 | 181,485 | Direct | |
| Dec 7, 2021 | Common Stock | PPurchaseAcquired | +75 | $5.61 | +$420.75 | 181,560 | Direct | |
| Dec 8, 2021 | Common Stock | PPurchaseAcquired | +75 | $6.15 | +$461.25 | 181,635 | Direct | |
| Dec 9, 2021 | Common Stock | PPurchaseAcquired | +75 | $5.81 | +$435.75 | 181,710 | Direct | |
| Dec 10, 2021 | Common Stock | PPurchaseAcquired | +75 | $4.82 | +$361.5 | 181,785 | Direct | |
| Dec 13, 2021 | Common Stock | PPurchaseAcquired | +200 | $4.36 | +$872 | 181,985 | Direct | |
| Dec 14, 2021 | Common Stock | PPurchaseAcquired | +200 | $4.28 | +$856 | 182,185 | Direct | |
| Dec 15, 2021 | Common Stock | PPurchaseAcquired | +200 | $4.29 | +$858 | 182,385 | Direct | |
| Dec 16, 2021 | Common Stock | PPurchaseAcquired | +240 | $4.53 | +$1,087.2 | 182,625 | Direct | |
| Dec 17, 2021 | Common Stock | PPurchaseAcquired | +240 | $4.17 | +$1,000.8 | 182,865 | Direct | |
| Dec 20, 2021 | Common Stock | PPurchaseAcquired | +276 | $4.33 | +$1,195.08 | 183,141 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.